Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

Over the last 12 months, Google’s efforts to use artificial intelligence to accelerate drug design have achieved breakthroughs in mimicking human biology and won its top scientists the Nobel Prize in Chemistry. Now Isomorphic Labs, the division within the software giant meant to develop and commercialize the technology, is taking another big step: raising money…

Read More
H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics

H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics

The Trump administration has canceled funding for dozens of studies seeking new vaccines and treatments for Covid-19 and other pathogens that may cause future pandemics. The government’s rationale is that the Covid pandemic has ended, which “provides cause to terminate Covid-related grant funds,” according to an internal N.I.H. document viewed by The New York Times….

Read More
Senators Press Marty Makary on Abortion Pills and Vaccines

Senators Press Marty Makary on Abortion Pills and Vaccines

At a confirmation hearing for Dr. Marty Makary on Thursday, senators focused heavily on the safety of the abortion pill, with Republican lawmakers urging him to restrict access and Democratic lawmakers demanding that he maintain its current availability. Dr. Makary, President Trump’s nominee to lead the Food and Drug Administration, signaled that he shared Republicans’…

Read More
Florida Seeks Drug Prescription Data With Names of Patients and Doctors

Florida Seeks Drug Prescription Data With Names of Patients and Doctors

Florida’s insurance regulator has demanded an unusually intrusive trove of data on millions of prescription drugs filled in the state last year, including the names of patients taking the medications, their dates of birth and doctors they’ve seen. The Florida Office of Insurance Regulation in January sought this information from pharmacy benefit managers like UnitedHealth’s…

Read More
F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only drug approved for treatment-resistant schizophrenia, among the most devastating of mental illnesses. The agency announced on Monday that it was eliminating a requirement that patients submit blood tests before their prescriptions can be filled. Clozapine,…

Read More